Tenofovir Alafenamide Hemifumarate TAF CAS 1392275-56-7 Hale Hana API Anti-HIV Kiʻi Kiʻekiʻe

Tenofovir Alafenamide Hemifumarate TAF CAS 1392275-56-7 API Factory Anti-HIV Mea Kiʻekiʻe

ʻO ka wehewehe pōkole:

Inoa: Tenofovir Alafenamide Hemifumarate (TAF)

CAS: 1392275-56-7

Keʻokeʻo a aneane keʻokeʻo keʻokeʻo a i ʻole ka pauka Crystalline

ʻIke: 98.0%~102.0%

ʻO kahi prodrug no Tenofovir, hoʻohana ʻia me ka lāʻau lapaʻau no ka mālama ʻana i ka maʻi HIV-1

ʻO ke kūlana kiʻekiʻe, ka hana kālepa

Inquiry: alvin@ruifuchem.com

E hoʻouna i ka leka uila iā mākou

Huahana Huahana

Nā Huahana Pili

Huahana Huahana

wehewehe:

Nā Mea Kūʻai Kūʻai ʻo Tenofovir e pili ana:
Tenofovir CAS: 147127-20-6
Tenofovir Disoproxil Fumarate CAS 202138-50-9
Tenofovir Alafenamide Hemifumarate CAS 1392275-56-7
Chloromethyl Isopropyl Carbonate CAS 35180-01-9
Diethyl (p-Toluenesulfonyloxymethyl)phosphonate CAS 31618-90-3
(R)-(+)-Propylene Carbonate CAS 16606-55-6
(R)-9-(2-Hydroxypropyl)adenine CAS 14047-28-0
Diethyl (Hydroxymethyl)phosphonate CAS 3084-40-0
Adenine CAS 73-24-5

Na Waiwai Kemika:

Inoa Kimia	ʻO Tenofovir Alafenamide Hemifumarate
Nā huaʻōlelo like	TAF;GS-7340 Hemifumarate
Helu CAS	1392275-56-7
Helu CAT	RF-API91
Kūlana Kūʻai	Ma ka waihona, ʻoi aku ka nui o ka hana a hiki i nā haneli kilogram
ʻĀpana Molekala	C25H33N6O9P
Kaumaha Molecular	592.55
Ka Mahana Waihona	Hoʻopaʻa ʻia i loko o ka maloʻo, ka wela lumi
Brand	Kemika Ruifu

Nā kikoʻī:

'ikamu	Nā kikoʻī
Ka nana aku	Keʻokeʻo a aneane keʻokeʻo keʻokeʻo a i ʻole ka pauka Crystalline
Ka hikiwawe	Hiki ke hoʻoheheʻe ʻia i ka Dimethylformamide, a me ka Methanol;Hiki i ka wai a me ka THF;Hiki ke hoʻoheheʻe ʻia i loko o ka Acetonitrile a ʻaʻole hiki ke hoʻoheheʻe ʻia i ka Dichloromethane a me Toluene
ʻIkepili A	Pono e kūlike ka spectra absorption IR me ka kuhikuhi
ʻIkepili B	ʻO ka manawa paʻa o ka piko nui o ka hāpana hāpana i loko o ka chromatogram hoʻoholo maʻiʻo e kūlike me kēlā o ka hopena kuhikuhi.
ʻIkepili C	ʻO ka manawa paʻa ʻo Fumaric Acid o ka piko nui i ka chromatogram hoʻoholo maʻiʻo e kūlike me ka piko o ka kuhikuhi.
Waiwai (na KF)	≤1.0%
Akaka o ka Haʻina	ʻAʻohe mea ʻike ʻia i loko o 2% (w/v) o ka wehewehe ʻana i ka Methanol Solution
Koena Solvent
Acetonitrile	≤410ppm
Ethanol	≤5000ppm
Dichloromethane	≤600ppm
Toluene	≤890ppm
Koena ma ka Ignition	≤0.10%
Nā Metala Kaumaha	≤20ppm
Na mea pili
PMPA	≤1.0%
PMPA Anhydride	≤0.75%
Phenyl PMPA hoʻokahi	≤1.0%
ʻO nā mea haumia ʻole i hōʻike ʻia	≤0.15%
Huina paumaele	≤2.0%
Isomer	≤1.0%
ʻO ka maʻiʻo o ka Fumaric Acid	9.0% ~ 13.0% (ma ke kumu anhydrous)
Palena Microbial
Huina Aerobic Microbial Helu	≤1000CFU/g
Huina Huna a me Molds	≤100CFU/g
Escherichia Coli	ʻAʻole
Hoʻāʻo	98.0% ~ 102.0% (ma ke kumu anhydrous a me ka solvent-free kumu)
Kūlana hoʻāʻo	Kūlana ʻoihana

Pūʻolo a me ka waiho ʻana:

Pūʻolo: ʻO ka ʻōmole, ʻeke ʻeke alumini, pahu pahu pahu, 25kg / pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.

Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;Palekana mai ka malamalama, ka ma'ū a me ka pest infestation.

Pono:

FAQ:

Noi:

ʻO Tenofovir Alafenamide Hemifumarate (TAF, GS-7340 hemifumarate), CAS 1392275-56-7, he nucleotide reverse transcriptase inhibitor (NRTIs) a me ka prodrug novel o Tenofovir (TFV).Ma ka pale ʻana i ka reverse transcriptase, pale ʻo TAF i ka maʻi HIV mai ka hoʻonui ʻana a hiki ke hōʻemi i ka nui o ka maʻi HIV i loko o ke kino.ʻO Tenofovir alafenamide kahi prodrug, ʻo ia hoʻi he lāʻau lapaʻau ʻole ia.I loko o ke kino, hoʻololi ʻia ka tenofovir alafenamide i Tenofovir diphosphate (TFV-DP).Ua ʻae ʻia ʻo Tenofovir Alafenamide Fumarate i Nowemapa 2015 no ka mālama ʻana i ka maʻi HIV-1.